Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants

NCT06133478 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: NUV001 active cohort 1
DRUG: NUV001 active cohort 2
DRUG: NUV001 active cohort 3
DRUG: NUV001 active cohort 4
DRUG: NUV001 placebo cohort 1
DRUG: NUV001 placebo cohort 2
DRUG: NUV001 placebo cohort 3
DRUG: NUV001 placebo cohort 4

Sponsor

Nuvamid SA

Collaborators

[object Object]
[object Object]
[object Object]